What colour is tirzepatide, and what does it tell you?

Tirzepatide solution in the Mounjaro KwikPen should be clear, colourless, and free of particles before every injection.
A reddish, cloudy, or murky appearance (sometimes described as a tirzepatide red colour) is a sign the pen may be degraded, damaged, or counterfeit.
Improper storage (particularly exposure to freezing temperatures or direct heat) is the most common reason a legitimate pen changes appearance.
The MHRA and Eli Lilly's published product information are the authoritative sources on visual inspection; always cross-check with the Patient Information Leaflet supplied with your pen.

Tirzepatide solution, as supplied in the Mounjaro KwikPen, is clear and colourless. That's the short answer. If the liquid in your pen looks cloudy, discoloured, or has visible particles floating in it, the pen should not be used — that's a practical check that takes under a minute and could genuinely matter. Mounjaro is a prescription-only medicine, so any questions about whether your specific pen is safe to use belong with your prescribing team or the Patient Information Leaflet, but understanding what the solution should look like is straightforward clinical education anyone can benefit from.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the colour of your tirzepatide pen actually tells you — and when to act on it

What should tirzepatide solution look like in the KwikPen?

The Mounjaro KwikPen contains a pre-mixed aqueous solution of tirzepatide. According to Eli Lilly's published product information and the Mounjaro SmPC on the eMC, the solution should appear clear and colourless. There is no visible tint, no cloudiness, and no sediment. If you hold the pen up to a decent light source (a window works well) you should be able to see straight through the liquid with no obstruction.

Some people notice a very faint haze when the pen has just come out of the fridge and is still cold. Letting it sit at room temperature for a few minutes, as recommended before injecting, usually resolves this. If the haze remains after the pen has warmed, that is worth flagging to your prescriber.

Each pen contains enough solution for four weekly doses, so visual inspection before each use is a habit worth building. The whole check takes seconds: look at the pen, not just the window, and make sure the cartridge area appears clear before you inject.

Why might a tirzepatide pen appear red, cloudy, or discoloured?

A tirzepatide red colour, or any visible discolouration, is not normal and points to one of several problems. The most common cause in genuine pens is temperature damage. Tirzepatide must be refrigerated at 2–8°C; if it freezes, or if it is left in a hot car or direct sunlight for an extended period, the protein-based molecule can degrade. Degraded solution may look cloudy, discoloured, or develop floating particles.

A second, more serious possibility is that the pen is counterfeit. The MHRA has warned repeatedly about fake weight-loss pens sold through social media and websites that supply these medicines without a prescription. Some seized counterfeits have been found to contain insulin rather than tirzepatide, an error that can be dangerous. If the colour, texture, or labelling of your pen looks unusual and you did not obtain it through a GPhC-registered pharmacy, you can report a suspect product via the MHRA's Yellow Card scheme.

You can learn more about what cold or freezing temperatures do to tirzepatide if storage conditions are a concern.

Does the colour differ between Mounjaro doses?

No. All six licensed Mounjaro strengths (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg) contain a clear, colourless solution. The dose strength is identified by the pen label and the coloured pen cap, not by any visible tint in the liquid itself. Eli Lilly uses distinct cap and label colours to help patients and clinicians tell the 2.5 mg starter pen from the 15 mg maintenance strength at a glance, but the solution inside every pen looks identical.

This is a common point of confusion when people search for a tirzepatide colour guide. The colour-coded cap is a practical safety feature, not a sign that different doses contain differently coloured liquids. If you are ever unsure which strength you have received, the label on the pen is the definitive reference. You can read a broader overview of what tirzepatide is and how it works as a starting point if you are new to this treatment.

For context on how Mounjaro sits alongside other weight-loss options, the Mounjaro vs tirzepatide page explains the naming relationship and licensed indications clearly.

What should you do if your pen looks wrong?

Do not use it. That is the straightforward advice, and it is consistent with what the Patient Information Leaflet states. Contact your pharmacy or prescriber before injecting. If you obtained your pen through a regulated service, they can advise whether a replacement is appropriate and help you understand whether the issue was storage-related.

If you are questioning whether your current provider is legitimate, the GPhC pharmacy register allows anyone to verify a UK online pharmacy in moments. Pharmacies dispensing prescription medicines legally will appear there. This matters for colour reasons too: counterfeit pens are far more likely to look wrong than genuine product stored correctly, so where you source your treatment and how it is stored are directly linked to what you see in the pen cartridge.

For separate but related information, the changes some people notice in urine colour on Mounjaro are covered on their own page. And if you are still deciding whether tirzepatide might be clinically appropriate for you, our weight-loss treatment overview and the Mounjaro cost context page may both be useful reading before taking the next step.

Tirzepatide is a prescription-only medicine, and a prescriber assesses your full picture before any treatment begins. If you would like to find out whether you could be eligible, and want to understand the tirzepatide l formulation details as part of that research, checking your eligibility starts with a free consultation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions